Novartis Capital Corp. 2.2% 14-AUG-2030 risks and ratings

Below, we've gathered key metrics for US66989HAR9 risk analysis: see the bond security level, means of inflation protection, issuer rating, and more to evaluate how reliable the US66989HAR9 bonds are and make an informed decision.